Literature DB >> 26287978

Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

Darrick K Li1, Raymond T Chung2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26287978      PMCID： PMC4666792          DOI： 10.1002/cncr.29650

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

Review 1.  Screening for hepatocellular carcinoma in chronic liver disease: a systematic review.

Authors:  Devan Kansagara; Joel Papak; Amirala S Pasha; Maya O'Neil; Michele Freeman; Rose Relevo; Ana Quiñones; Makalapua Motu'apuaka; Janice H Jou
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

2.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

Review 3.  Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.

Authors:  Darrick K Li; Raymond T Chung
Journal:  Cancer       Date:  2015-06-16       Impact factor: 6.860

4.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

5.  Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease.

Authors:  Andrew J Leidner; Harrell W Chesson; Fujie Xu; John W Ward; Philip R Spradling; Scott D Holmberg
Journal:  Hepatology       Date:  2015-03-16       Impact factor: 17.425

6.  Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.

Authors:  Mehdi Najafzadeh; Karin Andersson; William H Shrank; Alexis A Krumme; Olga S Matlin; Troyen Brennan; Jerry Avorn; Niteesh K Choudhry
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

7.  Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.

Authors:  Jagpreet Chhatwal; Fasiha Kanwal; Mark S Roberts; Michael A Dunn
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

8.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

9.  Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.

Authors:  Amit G Singal; Anjana Pillai; Jasmin Tiro
Journal:  PLoS Med       Date:  2014-04-01       Impact factor: 11.069
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.